S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

RGEN

REPLIGEN CORP
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
167.60
−2.01 −1.19%
USD · close Sep 4

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$14M$5M−66.3%0.09$32.8M$5.3M$27.4MJul 29
Q1 2026 · Mar 31$15.9M$8.3M+42.9%0.15$28.3M$4.7M$23.6MMay 6
Q4 2025 · Dec 31derived$17.9M$13.3M0.23$25.7M$8.2M$17.6MFeb 26
Q3 2025 · Sep 30$16.8M$14.9M0.26$48.1M$4.7M$43.4MNov 4
Q2 2025 · Jun 30$13.9M$14.9M+160.2%0.26$28.6M$7.1M$21.5MJul 29
Q1 2025 · Mar 31$6.6M$5.8M+76.9%0.10$15M$3.6M$11.4MMay 6
Q4 2024 · Dec 31derived−$36.5M−$33.9M-0.61$39.2M$5.5M$33.6MFeb 26
Q3 2024 · Sep 30−$7.8M−$654K−103.9%-0.01$49.3M$7M$42.3MNov 4
Q2 2024 · Jun 30$5.5M$5.7M0.10$42.2M$4.8M$37.4MAug 7
Q1 2024 · Mar 31$3.8M$3.3M0.06$44.7M$8.3M$36.4MApr 29
Q4 2023 · Dec 31derived$9.9M−$16.4M-0.28$29.1M$11.1M$18MFeb 26
Q3 2023 · Sep 30$4.7M$16.9M0.30$39.2M$8.4M$30.8MNov 18

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$55.2M$48.9M0.86$117.4M$23.5M$93.9M$0
FY2024 · to Dec 31−$35.1M−$25.5M-0.46$175.4M$25.7M$149.7M$0
FY2023 · to Dec 31$47.7M$35.6M0.63$113.9M$36.2M$77.7M$14.4M
FY2022 · to Dec 31$224.7M$186M3.24$172.1M$84.8M$87.2M$0
FY2021 · to Dec 31$167.2M$128.3M2.24$119M$67.1M$51.9M$0
FY2020 · to Dec 31$69.8M$59.9M1.11$62.6M$22.5M$40.2M

Every number comes from REPLIGEN CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch RGEN. Know when insiders buy.
One email the day a filing lands. Free.